Foundation Fighting Blindness Retinal Degeneration Fund
Director
- 2025
- Oct 2, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Foundation Fighting Blindness Retinal Degeneration Fund files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Cam Gallagher - $324K in IRD purchases and sales in the last 12 months
- George Magrath - $205K in IRD purchases and sales in the last 12 months
- Robert E. Gagnon - $191K in IRD purchases and sales in the last 12 months
- Benjamin R. Yerxa - $61K in IRD purchases and sales in the last 12 months
- Ashwath Jayagopal - $58K in IRD purchases and sales in the last 12 months
- Joseph K. Schachle - $58K in IRD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Foundation Fighting Blindness Retinal Degeneration Fund?
Foundation Fighting Blindness Retinal Degeneration Fund is a trust, tracked as Director of Opus Genetics, Inc. (IRD). InsiderAlpha holds 3 primary Form 4 filings for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Foundation Fighting Blindness Retinal Degeneration Fund submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Foundation Fighting Blindness Retinal Degeneration Fund been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($10.15M) across all tracked filings.
